81 FR 20422 - Sunshine Act Meeting

FOREIGN CLAIMS SETTLEMENT COMMISSION

Federal Register Volume 81, Issue 67 (April 7, 2016)

Page Range		20422-20422
FR Document		2016-08019

Federal Register, Volume 81 Issue 67 (Thursday, April 7, 2016)

[Federal Register Volume 81, Number 67 (Thursday, April 7, 2016)]
[Notices]
[Page 20422]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-08019]


-----------------------------------------------------------------------

FOREIGN CLAIMS SETTLEMENT COMMISSION

[F.C.S.C. Meeting and Hearing Notice No. 4-16]


Sunshine Act Meeting

    The Foreign Claims Settlement Commission, pursuant to its 
regulations (45 CFR part 503.25) and the Government in the Sunshine Act 
(5 U.S.C. 552b), hereby gives notice in regard to the scheduling of 
open meetings as follows:

Thursday, April 14, 2016

10:00 a.m.--Oral hearings on Objection to Commission's Proposed 
Decision in Claim No. LIB-III-012.

11:30 a.m.--Issuance of Proposed Decisions in claims against Iraq.

    Status: Open.

    All meetings are held at the Foreign Claims Settlement Commission, 
600 E Street NW., Washington, DC. Requests for information, or advance 
notices of intention to observe an open meeting, may be directed to: 
Patricia M. Hall, Foreign Claims Settlement Commission, 600 E Street 
NW., Suite 6002, Washington, DC 20579. Telephone: (202) 616-6975.

Brian M. Simkin,
Chief Counsel.
[FR Doc. 2016-08019 Filed 4-5-16; 8:45 am]
 BILLING CODE 4410-BA-P

20422 Federal Register / Vol. 81, No. 67 / Thursday, April 7, 2016 / Notices

Controlled substance Schedule

Phenmetrazine (1631) ................................................................................................................................................................................. II
Amobarbital (2125) ...................................................................................................................................................................................... II
Pentobarbital (2270) .................................................................................................................................................................................... II
Secobarbital (2315) ..................................................................................................................................................................................... II
Glutethimide (2550) ..................................................................................................................................................................................... II
Nabilone (7379) ........................................................................................................................................................................................... II
1-Phenylcyclohexylamine (7460) ................................................................................................................................................................. II
Phencyclidine (7471) ................................................................................................................................................................................... II
Phenylacetone (8501) ................................................................................................................................................................................. II
1-Piperidinocyclohexanecarbonitrile (8603) ................................................................................................................................................ II
Alphaprodine (9010) .................................................................................................................................................................................... II
Anileridine (9020) ........................................................................................................................................................................................ II
Etorphine HCI (9059) .................................................................................................................................................................................. II
Dihydrocodeine (9120) ................................................................................................................................................................................ II
Diphenoxylate (9170) .................................................................................................................................................................................. II
Ecgonine (9180) .......................................................................................................................................................................................... II
Ethylmorphine (9190) .................................................................................................................................................................................. II
Levomethorphan (9210) .............................................................................................................................................................................. II
Levorphanol (9220) ..................................................................................................................................................................................... II
Isomethadone (9226) .................................................................................................................................................................................. II
Meperidine (9230) ....................................................................................................................................................................................... II
Meperidine intermediate-A (9232) ............................................................................................................................................................... II
Meperidine intermediate-B (9233) ............................................................................................................................................................... II
Meperidine intermediate-C (9234) ............................................................................................................................................................... II
Metazocine (9240) ....................................................................................................................................................................................... II
Metopon (9260) ........................................................................................................................................................................................... II
Dextropropoxyphene, bulk (non-dosage forms) (9273) .............................................................................................................................. II
Dihydroetorphine (9334) .............................................................................................................................................................................. II
Levo-alphacetylmethadol (9648) ................................................................................................................................................................. II
Noroxymorphone (9668) .............................................................................................................................................................................. II
Phenazocine (9715) .................................................................................................................................................................................... II
Piminodine (9730) ....................................................................................................................................................................................... II
Racemethorphan (9732) .............................................................................................................................................................................. II
Racemorphan (9733) ................................................................................................................................................................................... II
Alfentanil (9737) .......................................................................................................................................................................................... II
Remifentanil (9739) ..................................................................................................................................................................................... II
Sufentanil (9740) ......................................................................................................................................................................................... II
Carfentanil (9743) ........................................................................................................................................................................................ II
Tapentadol (9780) ....................................................................................................................................................................................... II
Bezitramide (9800) ...................................................................................................................................................................................... II
Moramide-intermediate (9802) .................................................................................................................................................................... II

The company plans to import FOREIGN CLAIMS SETTLEMENT may be directed to: Patricia M. Hall,
analytical reference standards for COMMISSION Foreign Claims Settlement Commission,
distribution to its customers for research 600 E Street NW., Suite 6002,
[F.C.S.C. Meeting and Hearing Notice No.
and analytical purposes. Placement of 4–16]
Washington, DC 20579. Telephone:
these drug codes onto the company’s (202) 616–6975.
registration does not translate into Sunshine Act Meeting Brian M. Simkin,
automatic approval of subsequent Chief Counsel.
The Foreign Claims Settlement
permit applications to import controlled
Commission, pursuant to its regulations [FR Doc. 2016–08019 Filed 4–5–16; 8:45 am]
substances. Approval of permit (45 CFR part 503.25) and the BILLING CODE 4410–BA–P
applications will occur only when the Government in the Sunshine Act (5
registrant’s business activity is U.S.C. 552b), hereby gives notice in
consistent with what is authorized regard to the scheduling of open DEPARTMENT OF JUSTICE
under 21 U.S.C. 952(a)(2). Authorization meetings as follows: [OMB Number 1121–0302]
will not extend to the import of FDA
approved or non-approved finished Thursday, April 14, 2016
Agency Information Collection
dosage forms for commercial sale. 10:00 a.m.—Oral hearings on Objection Activities; Proposed eCollection
Dated: March 29, 2016. to Commission’s Proposed Decision eComments Requested;
in Claim No. LIB–III–012. Reinstatement, With Change, of a
Louis J. Milione,
11:30 a.m.—Issuance of Proposed Previously Approved Collection for
mstockstill on DSK4VPTVN1PROD with NOTICES

Deputy Assistant Administrator. Decisions in claims against Iraq. Which Approval Has Expired: 2016
[FR Doc. 2016–07947 Filed 4–6–16; 8:45 am]
Status: Open. Supplemental Victimization Survey
BILLING CODE 4410–09–P
All meetings are held at the Foreign (SVS)
Claims Settlement Commission, 600 E AGENCY: Bureau of Justice Statistics,
Street NW., Washington, DC. Requests Department of Justice.
for information, or advance notices of
ACTION: 30-Day notice.
intention to observe an open meeting,

VerDate Sep<11>2014 16:35 Apr 06, 2016 Jkt 238001 PO 00000 Frm 00104 Fmt 4703 Sfmt 4703 E:\FR\FM\07APN1.SGM 07APN1

Document Created: 2016-04-06 23:43:39
Document Modified: 2016-04-06 23:43:39

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		81 FR 20422